crinecerfont

Drug ingredient

CAS 752253-39-7

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 752253-39-7
US productionNot reported
Import value, 2024$447M
Top sourceChina 31%

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Production is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.

Where It Comes From

Customs basis: HS 293410 · basket

These shares come from HS customs code 293410, which covers 83 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.

Source Countries
CN 31%ChinaDE 25%GermanyMX 19%MexicoJP 13%JapanIN 5%India
3 FDA-registered drug labelers
Catalent Pharma Solutions, LLC
Has Healthcare Advanced Synthesis SA
Neurocrine Biosciences, Inc.

Why It Matters

Sectors
Health
Downstream Uses

Appears in 1 drug and cosmetic product listings (FDA).

  • •Crenessity
FDA Shortage Status
No Shortage
Shortage History
  • to be discontinued

    Crinecerfont Capsule

    Shortage listed since April 28, 2026

See all current drug shortages

Chemical Identity

CAS752253-39-7
PubChem CID5282340
DTXSIDDTXSID10996687
FormulaC27H28ClFN2OS
Mol. Weight483 g/mol
SMILESCC1=C(C=C(C=C1)C(CC2CC2)N(CC#C)C3=NC(=C(S3)C)C4=C(C=C(C(=C4)C)OC)Cl)F

Data Sources

Brief citations

crinecerfont (CAS 752253-39-7) https://chemicalindependence.com/chemical/752253-39-7/ PubChem: 5282340. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/5282340 FDA National Drug Code directory: CAS 752253-39-7. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 752253-39-7. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/ US Census international trade: HS 293410 for CAS 752253-39-7. Reporting year: 2024. https://usatrade.census.gov/